Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linifanib in k-Ras Mutated Colorectal Cancer
NCT01365910Phase 2Terminated
- Sponsor
- Vanderbilt-Ingram Cancer Center
- Start
- Jun 2011
- Primary completion
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of linifanib in colorectal cancer (CRC), sponsored by Vanderbilt-Ingram Cancer Center. Started Jun 2011; status: terminated.
02
Drugs
linifanib
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT01365910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01365910.